Updated:
Zhejiang Yanglin Biotechnology
Zhejiang Yanglin Biotechnology is a corporate investor based in Hangzhou, China. It focuses on investments in Asia. The firm has committed to one fund.
Zhejiang Yanglin Biotechnology
Zhejiang Yanglin Biotechnology is a corporate investor based in Hangzhou, China. It focuses on investments in Asia. The firm has committed to one fund.
General information
Firm type
Corporate Investor
Location
Region
Asia
Country
China
City
Hangzhou
Corporate office
Hangzhou, Zhejiang, China
Principals
Chairman (Name Undisclosed)
Chairman
Sector focus
Frequently asked questions
What investment stages does Zhejiang Yanglin Biotechnology target?
The firm's mandate covers the full venture lifecycle: seed, start-up, expansion, and late-stage venture. This broad stage coverage allows it to support companies from preclinical research through to commercialization. Typical corporate biotech investors in China maintain wide stage flexibility to capture innovation early while reserving capacity for later-stage de-risked assets closer to market.
Is Zhejiang Yanglin Biotechnology structured as a standalone fund or a balance-sheet investor?
The firm operates as a balance-sheet investor, deploying capital directly from its parent company rather than raising discrete funds from external limited partners. This structure gives it permanent capital and removes the fundraising cycle constraints that shape behavior at traditional venture firms, but also limits public transparency since no fund documents are filed with regulators.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: